karanjin has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balan, T; Begum, MY; Chandramohan, V; Chidambaram, K; Fuloria, NK; Fuloria, S; Gan, SH; Gnanaraj, C; Jeyabalan, S; Lum, PT; Rani, NNIM; Sekar, M; Stephenie, S; Subramaniyan, V; Swain, SS; Thangavelu, L | 1 |
1 other study(ies) available for karanjin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
Topics: Alzheimer Disease; Animals; Benzopyrans; Drug Design; Molecular Docking Simulation; Molecular Dynamics Simulation; Parkinson Disease | 2022 |